http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2243774-C1

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
filingDate 2003-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2005-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee0c0d0965a9e13b5fd755512862b30d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0669240e692e6de073c686b86bb30a49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e93c2865b4676bb6537c6ad73b73177
publicationDate 2005-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2243774-C1
titleOfInvention Method for treatment of chronic lympholeukosis
abstract FIELD: medicine, oncology. n SUBSTANCE: invention relates to a method for treatment of chronic lympholeukosis. Method involves intravenous drop and jet administration of antitumor chemopreparations and carrying out the autochemotherapy. At the 1-st and 8-th day of treatment cyclophosphan in the dose 750 mg/m 2 , vincristine in the dose 1.4 mg/m 2 and doxorubicin in the dose 30 mg/m 2 incubated with 200 ml of autoblood are administrated to patients. From the 1-st to 14-th day of treatment prednisolone is used every day in the therapeutic dose. The treatment course is repeated in 30-35 days depending on blood indices and patient state. The total treatment of courses is 4-5. Method provides reducing cardiotoxicity of doxorubicin and cumulative toxicity of chemopreparations that allows carrying out administration of antitumor chemopreparations in the full volume to patients of elderly age groups. n EFFECT: improved method for treatment. n 1 ex
priorityDate 2003-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535365
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID66000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506586
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID66000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5755
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535314

Total number of triples: 25.